Dealing with Corruption Risks, Compliance and Value Management

January 2019. Global analytical and medical diagnostic companies are active in diverse jurisdictions and business cultures. Thus they are quite vulnerable to internal and external deviance. For many years the Eurofins Group has been escaping scandals which plague others in the laboratory sector, and a number of ethics and other behavioural codes are publicly available. But is on paper enough? How does the company enforce compliance and prevent corruptive practice? Hugues Vaussy, Director of Group Finance with global responsibilities for Insurance and Risk Management, Investor Relations, as well as capital market transactions answered B2Bioworld's questions.Reading time: 13 min

Read Now:
1,50 EUR (incl. 7% VAT)

Back to section